Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Sanz, Celia; Montero, Paula; MILARA, JAVIER; Pérez-Leal, Martín; Estornut, Cristina; Roger, Inés; Pérez-Fidalgo, J. Alejandro; Cortijo, Julio
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis ModelAutoría
Fecha de publicación
2022-01-22Editor
MDPICita bibliográfica
Montero, P.; Milara, J.; Pérez-Leal, M.; Estornut, C.; Roger, I.; Pérez-Fidalgo, A.; Sanz, C.; Cortijo, J. Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model. Int. J. Mol. Sci. 2022, 23, 1142. https:// doi.org/10.3390/ijms23031142Tipo de documento
info:eu-repo/semantics/articleVersión de la editorial
https://www.mdpi.com/1422-0067/23/3/1142Versión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Paclitaxel is a microtubule-stabilizing chemotherapeutic agent approved for the treatment
of ovarian, non-small cell lung, head, neck, and breast cancers. Despite its beneficial effects on
cancer and widespread use, ... [+]
Paclitaxel is a microtubule-stabilizing chemotherapeutic agent approved for the treatment
of ovarian, non-small cell lung, head, neck, and breast cancers. Despite its beneficial effects on
cancer and widespread use, paclitaxel also damages healthy tissues, including the skin. However, the
mechanisms that drive these skin adverse events are not clearly understood. In the present study, we
demonstrated, by using both primary epidermal keratinocytes (NHEK) and a 3D epidermis model,
that paclitaxel impairs different cellular processes: paclitaxel increased the release of IL-1α, IL-6,
and IL-8 inflammatory cytokines, produced reactive oxygen species (ROS) release and apoptosis,
and reduced the endothelial tube formation in the dermal microvascular endothelial cells (HDMEC).
Some of the mechanisms driving these adverse skin events in vitro are mediated by the activation
of toll-like receptor 4 (TLR-4), which phosphorylate transcription of nuclear factor kappa B (NF-κb).
This is the first study analyzing paclitaxel effects on healthy human epidermal cells with an epidermis
3D model, and will help in understanding paclitaxel’s effects on the skin. [-]
Publicado en
International Journal of Molecular Sciences. 2022, 23 (3), 1142. https://doi.org/10.3390/ijms23031142Entidad financiadora
Fondo Europeo de Desarrollo Regional (FEDER) | Instituto de Salud Carlos III | Gobierno de España | Generalitat Valenciana
Código del proyecto o subvención
PID2020-114871RB-I00 | PI20/01363 | CB06/06/0027 | 2017/023/UV
Título del proyecto o subvención
CIBERES | Regional Government Prometeo
Derechos de acceso
© 2022 by the authors
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [646]